WHO declares mpox a global health emergency
An outbreak of the viral disease formerly known as monkeypox continues to spread in Africa
What happened
The World Health Organization (WHO) declared an mpox outbreak in Africa a "public health emergency of international concern." The highly infectious strain of mpox, formerly called monkeypox, has jumped from the Democratic Republic of Congo (DRC) to a dozen other African countries.
Who said what
The spread and adaptability of this mpox strain is "very worrying," said WHO Director-General Tedros Adhanom Ghebreyesus. "A coordinated international response is needed to stop these outbreaks and save lives." The WHO last designated mpox a global emergency in 2022, when an outbreak affected nearly 100,000 people, "primarily gay and bisexual men, in 116 countries," The New York Times said. That outbreak killed about 200 people.
In the DRC, children make up "the majority of the 14,000 reported cases and 511 deaths so far" this year, NPR said. The global health emergency designation will unlock certain resources to help contain and neutralize this outbreak. But it's a "failure of the global community that things had to get this bad to release the resources needed," Michael Marks, a professor at the London School of Hygiene and Tropical Medicine, told The Associated Press.
What next?
Declaring mpox a global health emergency is "intended to prompt member countries to begin preparing for the virus' appearance and to share vaccines, treatments and other key resources with poorer nations," the Times said. The Centers for Disease Control and Prevention alerted American clinicians about the outbreak last week.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Rafi Schwartz has worked as a politics writer at The Week since 2022, where he covers elections, Congress and the White House. He was previously a contributing writer with Mic focusing largely on politics, a senior writer with Splinter News, a staff writer for Fusion's news lab, and the managing editor of Heeb Magazine, a Jewish life and culture publication. Rafi's work has appeared in Rolling Stone, GOOD and The Forward, among others.
-
Political cartoons for December 13Cartoons Saturday's political cartoons include saving healthcare, the affordability crisis, and more
-
Farage’s £9m windfall: will it smooth his path to power?In Depth The record donation has come amidst rumours of collaboration with the Conservatives and allegations of racism in Farage's school days
-
The issue dividing Israel: ultra-Orthodox draft dodgersIn the Spotlight A new bill has solidified the community’s ‘draft evasion’ stance, with this issue becoming the country’s ‘greatest internal security threat’
-
How dangerous is the ‘K’ strain super-flu?The Explainer Surge in cases of new variant H3N2 flu in UK and around the world
-
Stopping GLP-1s raises complicated questions for pregnancyThe Explainer Stopping the medication could be risky during pregnancy, but there is more to the story to be uncovered
-
Vaccine critic quietly named CDC’s No. 2 officialSpeed Read Dr. Ralph Abraham joins another prominent vaccine critic, HHS Secretary Robert F. Kennedy Jr.
-
This flu season could be worse than usualIn the spotlight A new subvariant is infecting several countries
-
More adults are dying before the age of 65Under the radar The phenomenon is more pronounced in Black and low-income populations
-
Tips for surviving loneliness during the holiday season — with or without peoplethe week recommends Solitude is different from loneliness
-
Scientists have developed a broad-spectrum snake bite antivenomUnder the radar It works on some of the most dangerous species
-
More women are using more testosterone despite limited researchThe explainer There is no FDA-approved testosterone product for women
